De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ascendis Health Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

A. Neethling

Algemeen directeur

R81.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.1yrs
Eigendom CEO	11.4%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.4yrs

Recente managementupdates

Recent updates

There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

Sep 23

CEO

A. Neethling (45 yo)

2.1yrs

Tenure

R81,000

Compensatie

Mr. A. Carl Neethling is CEO, Acting Chief Financial Officer & Director of Ascendis Health Limited from 2023. He served as Executive Director, Chief Transition Officer and Acting CEO of Ascendis Health Lim...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
A. Neethling	CEO, Acting CFO & Director	2.4yrs	R81.00k	11.44% ZAR 50.1m
Bharti Harie	Independent Chairman	2.4yrs	R773.00k	0.040% ZAR 175.4k
Karsten Uwe Harald Wellner	Independent Non-Executive Director	2.8yrs	R418.00k	0.20% ZAR 896.4k
Theunis Bruyn	Non-Executive Director	2yrs	R161.00k	geen gegevens
Hendrik Nolte	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ASC wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.4 jaar), wat duidt op een nieuw bestuur.

Ascendis Health Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director

Ascendis Health Limited, Annual General Meeting, Nov 30, 2023

Ascendis Health Limited Appoints Joseph Fine as Company Secretary

High number of new and inexperienced directors

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Recent updates

An undisclosed buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Alpvest Equities Proprietary Limited.

Ascendis Health Limited to Report Fiscal Year 2024 Results on Sep 03, 2024

Ascendis Health Limited to Report First Half, 2024 Results on Mar 28, 2024

Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director

Ascendis Health Limited, Annual General Meeting, Nov 30, 2023

Ascendis Health To Delist from JSE, Upon Deal Goes Through

Ascendis Health Limited Appoints Joseph Fine as Company Secretary

Ascendis Health Limited to Report Fiscal Year 2023 Results on Sep 29, 2023

There Is A Reason Ascendis Health Limited's (JSE:ASC) Price Is Undemanding

High number of new and inexperienced directors

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Ascendis Health Limited, Annual General Meeting, Nov 30, 2022

Ascendis Health Limited to Report Fiscal Year 2022 Results on Sep 28, 2022

Ascendis Health Limited Announces Board Changes

Ascendis Considers Delisting from JSE

Kefolile Health Investments Pty Ltd acquired an unknown minority interest in Ascendis Health Limited (JSE:ASC)

MMC International Health Holding S.L entered into sale of shares agreement to acquire Farmalider, S.A. from Ascendis Health Limited (JSE:ASC) for €5 million.

The management of Respiratory Care Africa (Pty) Ltd. agreed to acquire Respiratory Care Africa (Pty) Ltd. from Ascendis Health Limited (JSE:ASC) in a management buyout transaction.

First half 2021 earnings released: R0.63 loss per share (vs R0.16 profit in 1H 2020)

Independent Non-Executive Director has left the company

Ascendis Health Limited Announces Resignation of Yoza Jekwa, with Effect from 11 March 2021

Ascendis Health Limited to Report First Half, 2021 Results on Mar 31, 2021

New 90-day low: R0.66

An unknown buyer acquired an unknown minority stake in Ascendis Health Limited (JSE:ASC) from Public Investment Corporation Limited.

Ascendis Health Limited Approves Board Changes

New 90-day high: R0.81

Full year 2020 earnings released: R1.74 loss per share

Ascendis Health Limited Announces the Changes to Board Committees

New 90-day low: R0.56

Mary Bomela Resigns as Independent Non-Executive Director of Ascendis Health Limited with Effect from 31 October 2020

Ascendis Health Announces the Appointment of Cheryl-Jane (CJ) Kujenga as Chief Financial Officer, Effective 1 December 2020

Ascendis Health Limited Auditor Raises 'Going Concern' Doubt

New 90-day low: R0.58

Full year earnings released - R1.74 loss per share

Austell Pharmaceuticals Proprietary Limited agreed to acquire Dezzo Trading 392 Proprietary Limited from Ascendis Health Limited (JSE:ASC) for ZAR 80 million.

New 90-day low - R0.78

Ascendis Health Limited(JSE:ASC) dropped from S&P Global BMI Index

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd